Publication:
Systemic lupus erythematosus and antiphospholipid syndrome

dc.contributor.authorPlavsic, Aleksandra (24169362300)
dc.contributor.authorMiskovic, Rada (56394650000)
dc.contributor.authorRaskovic, Sanvila (6602461528)
dc.contributor.authorBogic, Mirjana (18333561400)
dc.contributor.authorBonaci Nikolic, Branka (10839652200)
dc.date.accessioned2025-06-12T20:17:52Z
dc.date.available2025-06-12T20:17:52Z
dc.date.issued2014
dc.description.abstractAntiphospholipid syndrome is an autoimmune disorder defined as association of vascular thrombosis and/or pregnancy complications with presence of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin and anti-β2 glycoprotein I). It is the most common cause of acquired thrombophilia, and can occur as an independent entity or in relation with other diseases, especially systemic lupus erythematosus. Presence of antiphospholipid syndrome in systemic lupus erythematosus is additional vaso occlusive factor in already present inflammation, bringing further risk for thrombotic events. Clinical and serological manifestations of antiphospholipid syndrome and systemic lupus erythematosus are very similar, so possible connection for these two autoimmune disorders is assumed. © 2014 Plavsic et al.
dc.identifier.urihttps://doi.org/10.3889/oamjms.2014.098
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85025132643&doi=10.3889%2foamjms.2014.098&partnerID=40&md5=3004fd41f4259d9b8a6c9ff9d2e8fbca
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/8634
dc.subjectAnticoagulant therapy
dc.subjectAntiphospholipid antibodies
dc.subjectAntiphospholipid syndrome
dc.subjectSystemic lupus erythematosus
dc.subjectThrombosis
dc.titleSystemic lupus erythematosus and antiphospholipid syndrome
dspace.entity.typePublication

Files